Canada: A New Era Of Canadian Defensive Tactics

"Defensive tactics other than shareholder rights plans will become more common and will attract a high level of regulatory scrutiny."

This was the prediction of securities regulators in Hecla, their first defensive tactics decision under Canada's new takeover bid regime.1 The Hecla decision is an important one: it articulates the regulators' approach to reviewing defensive measures under the new regime, highlighting the securities law perspective on the relative roles of target boards and shareholders in change-of-control transactions.

Securities law in Canada prioritizes protecting a target's shareholder interests; in contrast, corporate law demands that target boards consider non-shareholder interests and gives directors significant discretion under the business judgment rule to respond to a bid. While these regimes may seem to conflict, an alternative view is that they overlap: in the face of a bid, a target board may use defensive tactics in the exercise of their duties, up to the limit permitted by securities laws.

If, as Hecla predicts, a wider range of defensive tactics is indeed expected in the coming years, the question is: how will these measures be handled by securities regulators? We anticipate the development of a principle-based framework that, over time, will supplement Canada's defensive tactics policy and require regulators to balance the corporate and securities laws.

Poison Pills and the Old Regime

Under the old takeover bid regime, bids could expire in just 35 days, and target boards would typically implement "tactical" poison pills to buy more time to seek an alternative offer or create negotiating leverage. In response to the widespread use of poison pills, regulators developed a body of principles consistent with the mandate of protecting investor interests which allowed target boards to maintain a poison pill for a set time in the face of a hostile bid. In the view of securities regulators, reflected in Canada's defensive tactics policy (NP 62-202), a defensive tactic cannot be used to deny shareholder choice or access to a bid, and if it does, it will be set aside as contrary to the public interest.

Rise of Non-Pill Defensive Measures

The new takeover bid regime includes a new minimum bid period of 105 days, which changes how tactical poison pills will be treated by regulators.2 Absent exceptional circumstances, regulators are unlikely to allow a tactical poison pill to delay an unsolicited bid beyond the new 105-day minimum bid period. With more time to consider a hostile bid and seek value-enhancing alternatives, target boards may take steps that they believe are in the best interests of the corporation, including fending off an unwanted bid. This may cause target boards to consider taking other measures which may be appropriate as a matter of corporate law, but which may test the limits of Canadian securities law.

Regulators' Principled Framework

As their first defensive tactics decision under the new bid regime has demonstrated, the regulators' approach to reviewing non-pill tactics seeks to strike a balance that recognizes the principles of both corporate and securities law. Hecla involved a target undertaking a private placement concurrently with an unsolicited takeover bid. The Ontario and British Columbia regulators, in their joint decision, set out a two-step approach to determine whether to cease trade the private placement. First: does the target board's action have a corporate law purpose (such as raising capital)? And second: even if the action is intended to achieve a corporate law purpose, does it nevertheless have the effect of a defensive measure? To answer these questions, the regulators considered a list of factors, weighing both the corporate needs met by the target board's action and its relative impact on the outstanding bid.3

Even if a private placement may be considered a defensive tactic, the regulators will not necessarily intervene, acknowledging the need to balance corporate law's principle of deferring to a board's business judgment with the securities law principle of facilitating shareholder choice in the context of a change-of-control transaction. This new principled framework is likely to inform the approach regulators apply to other non-pill measures adopted by a target board in the face of a hostile bid.

Target Boards in a New Era of Defensive Tactics

If a target board's action is used as a tool to attract an M&A transaction to the benefit of shareholders, securities regulators are unlikely to intervene unless the effect of that action is considered abusive to shareholder rights and/or the capital markets. If, on the other hand, the target board acts to prevent a bid or protect a deal rather than encourage an unrestricted auction, the outcome is less certain. While such actions may be permissible under corporate law, securities regulators may intervene, effectively imposing a limit on the proper exercise of a target board's powers.

As Hecla suggests, targets may consider the appropriateness of effecting a private placement to a friendly shareholder, making it more difficult for a unsolicited bidder to achieve the new takeover bid 50% minimum tender requirement. However, without a proper business purpose, target boards of large-cap issuers will struggle to defend the legitimacy of a private placement undertaken at the same time as a bid.

Target boards will also continue to see the benefit of adopting a poison pill in order to regulate exempt purchases of target securities through creeping acquisitions and private agreement purchases, and prevent irrevocable lock-up agreements.

However, we would expect that the regulators would not generally permit a target board to maintain a poison pill if a bid has been accepted by a majority of disinterested shareholders and if the bid otherwise complies with the new takeover bid regime.


For securities regulators, target shareholders must ultimately decide the outcome of a bid, though they have acknowledged that they need to "tread warily" in this new era of defensive tactics. As they navigate how Canada's defensive tactics policy will operate relative to Canadian corporate law in the future, the regulators, who left the poison pill hearing business behind when the new bid regime took effect, are now planting firm first steps into the arena of defensive actions.


1 See Re Hecla Mining Company (2016), 39 OSCB 8927 (Hecla).

2 For background details on Canada's new takeover bid regime, click here to read our bulletin of February 26, 2016.

3 For details on the Dolly Varden and Hecla Mining dispute, and the commissions' decisions, click here to read our bulletin of October 25, 2016.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.